# Clinical Evaluation of Ropinirole CR-RLS ( SK&F101468)Tablets in Restless Legs Syndrome

> **NCT00530790** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 35 (actual)

## Conditions studied

- Restless Legs Syndrome

## Interventions

- **DRUG:** ropinirole controlled release (CR)-RLS

## Key facts

- **NCT ID:** NCT00530790
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08-23
- **Primary completion:** 2008-02-01
- **Final completion:** 2008-02-01
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2018-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00530790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00530790, "Clinical Evaluation of Ropinirole CR-RLS ( SK&F101468)Tablets in Restless Legs Syndrome". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00530790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*